economic
Archived signal
Advocacy group questions Medanta MD Naresh Trehan’s inclusion in panel on pharma marketing practices
In a representation to the Department of Pharmaceuticals, the group urges the government to replace Medanta chairman with a member free of potential conflicts of interest.
Reported by The Hindu
Read the complete report at The Hindu ↗
Verification notice
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
2 reports · 2 sources
The HinduAdvocacy group questions Medanta MD Naresh Trehan’s inclusion in panel on pharma marketing practicesThe HinduAdvocacy group questions Medanta MD Naresh Trehan’s inclusion in panel on pharma marketing practices9 recorded states
Signal first indexedP1 · 68% quality · 1 source
Corroboration 1→2 sources · quality 68→72P1 · 72% quality · 2 sources
Quality 72→76P1 · 76% quality · 2 sources
Quality 76→80P1 · 80% quality · 2 sources
Quality 80→84P1 · 84% quality · 2 sources
Quality 84→88P1 · 88% quality · 2 sources
Quality 88→92P1 · 92% quality · 2 sources
Quality 92→96P1 · 96% quality · 2 sources
Quality 96→99P1 · 99% quality · 2 sources